"The US Food and Drug Administration (FDA) has approved the tumor necrosis factor inhibitor adalimumab (Humira, AbbVie) for the treatment of moderate to severe hidradenitis suppurativa (HS), making it the first and only FDA-approved therapy"...
Topically applied Luxiq (betamethasone valerate foam) can be absorbed in sufficient amounts to produce systemic effects. (See PRECAUTIONS)
Luxiq (betamethasone valerate foam) is contraindicated in patients who are hypersensitive to betamethasone valerate, to other corticosteroids, or to any ingredient in this preparation.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 9/29/2008
Additional Luxiq Information
Luxiq - User Reviews
Luxiq User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Find out what women really need.